1. Adriamycin cardiomyopathy—risk factors
2. Doxorubicin versus mitomycin versus doxorubicin plus mitomycin in advanced breast cancer: A randomized study;Andersson M;Cancer Treat Rep,1986
3. Time- and dose-dependent changes in ejection fraction determined by radionuclide angiography after anthracycline therapy;Singer JW;Cancer Treat Rep,1978
4. Selective right ventricular dysfunction following doxorubicin therapy;Sperber AD;Isr J Med Sci,1987
5. Congestive heart failure due to adriamycin cardiotoxicity: Its natural history in children